This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




Text Version  RSS  Subscribe  Unsubscribe  Archive  Media Kit May 15, 2015
Home    About AST    Education    Meetings & Events    Public Policy    Contact Us  

 



SOCIETY NEWS

A New Year for the AST
AST
In his first blog as president, Dr. James Allan thanks the outgoing AST leaders and welcomes the new leadership as he highlights AST initiatives for the year ahead. Read more from Dr. Allan’s first blog post to see where the AST is headed. What would you like to see the AST accomplish this year? Let us know what you think in the blog’s comment section.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




New AST President and Board Members
AST
The AST announced James Allan, M.D., MBA, as president, and Anil Chandraker, M.D., as president-elect. They are joined by Ronald Gill, PhD, as secretary, and four new councilors-at-large: John Gill, M.D., MS; Deepali Kumar, M.D.; Jesse Schold, Ph.D., M Stat, MEd.; and Alexander Wiseman, M.D. Read more about the new board.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


AST Achievement Awards and Grants
AST
The AST announced this year's Achievement Award and Grant recipients at the recent American Transplant Congress. Read more to learn about the winners.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
 
You care about your transplant patients. And so do we. That’s why we’re introducing Astellas Cares—a new program that offers you customized tools, educational resources, and comprehensive support to help your patients care for their health. To register, visit AstellasCares.com/Transplant today.
 


AST Lifetime Achievement Award
AST
The AST awarded its highest honor, the Lifetime Achievement Award, to Donald Hricik, M.D., at the recent American Transplant Congress. This award honors a senior investigator whose lifelong work has advanced the field of transplantation. Read more about the award.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


ATC 2016 Program submission available
AST
The 2016 American Transplant Congress Program Planning Committee is now accepting program proposals for scientific sessions to be held June 11-15, 2016 in Boston, Massachusetts. Participate in the Call for Programs and share your experience and knowledge with leaders in the transplantation community from across the globe. The deadline to submit proposals is June 5, 2015.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  UCLA Immunogenetics Center

The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE
 


Education and Clinical Tools for the Independent Living Donor Advocate: A new webinar series
AST
The AST Live Donor Community of Practice announces the Education and Clinical Tools for the Independent Living Donor Advocate (ILDA) webinar series. This nine-part series starts on May 27 and runs through December, offering valuable resources for ILDAs. The entire series is free to AST members and their associates, just register with an AST member username and password at www.myAST.org/ILDA.

Non-members can purchase access to all nine webinars for just $200. Eligible non-members can join AST as a non-doctoral member and the webinar series is included in their $90 annual dues. Find out more at www.myAST.org/ILDA.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Update on hepatitis C eradication: Webinar May 19
AST
Register today for the final webinar in AST's 2014-2015 Timely Topics in Transplantation series, "Update on Hepatitis C Eradication Including Renal Clearance and Dosing and Important DDI Highlights." Presented by Kimberly Brown, M.D., and Tiffany Kaiser, PharmD, this webinar focuses on emerging therapies for HCV in transplant patients with specific attention to drug-drug interactions and limitations in patients with renal disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  Missing or Broken Doppler Probes?

VTI’s disposable intraoperative Doppler probes are ready to verify technical results. There’s no longer the need to perform sterilization that frequently causes irreversible damage to the traditional Doppler probes. Advantages include fewer replacements of conventional Doppler probes damaged during sterilization, OR time saved, and a reduction in specialty procedures.
 


TRANSPLANT NEWS


Assessing antibody strength: Comparison of MFI, C1q, and titer information
American Journal of Transplantation
The presence of donor-specific HLA antibodies before or after transplantation may have different implications based on the antibody strength. Yet, current approaches do not provide information regarding the true antibody strength as defined by antigen–antibody dissociation rate. To assess currently available methods, we compared between neat mean fluorescence intensity (MFI) values, C1q MFI values, ethylenediaminetetraacetic acid (EDTA)-treated samples, as well as titration studies and peak MFI values of over 7000 Luminex-based single-antigen HLA antibody data points.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Reassessing medical risk in living kidney donors
Journal of the American Society of Nephrology
The short- and long-term effects of unilateral nephrectomy on living donors have been important considerations for 60 years. Short-term risk is well established (0.03 percent mortality and less than 1 percent risk of major morbidity), but characterization of long-term risk is evolving. Relative to the general population, risk of mortality, ESRD, hypertension, proteinuria, and cardiovascular disease is comparable or lower.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


COMMITMENT TO CARE
Raptor's mission is to develop and commercialize life-altering therapeutics that treat rare, debilitating, and often fatal diseases.
LEARN MORE
Advertise here!

To find out how to feature your company in the AST eNewsletter and other advertising opportunities, Contact Tom Crist at 972-402-7724.
MORE


Prediction of medication non-adherence and associated outcomes in pediatric kidney transplant recipients
Pediatric Tx
Studies have continued to evaluate risk factors associated with post-transplant non-adherence in pediatric patients. However, many of these studies fail to evaluate how risk factors can be utilized to predict MNA. The aims of this study were to (i) determine salient risk factors associated with MNA to develop an adequate predictive risk model and (ii) assess transplant outcomes based on the presence of MNA in a large, diverse cohort of pediatric KTX recipients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Hand and upper extremity transplantation: An update of outcomes in the worldwide experience
Plastic and Reconstructive Surgery
Hand/upper extremity transplantation is the most common form of vascularized composite allotransplantation performed to date. An Update of worldwide outcomes is reported. The authors summarize the international experience with 107 known transplanted hand/upper extremities in 72 patients. Data from published medical literature, national and international meetings, lay press reports, and personal communications were utilized to provide the most up-to-date summary.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Single- vs double-lung transplantation in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis since the implementation of lung allocation based on medical need
JAMA via PubMed
Outcomes of single- and double-lung transplantation have not been rigorously assessed since the allocation of donor lungs according to medical need as quantified by the Lung Allocation Score, which began in 2005. The aim of this study was to compare outcomes in single- and double-lung transplant recipients since the Lung Allocation Score was implemented.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Role of patient factors and practice patterns in determining access to liver waitlist (American Journal of Transplantation)
Critical factors associated with missing follow-up data for living kidney donors in the United States (American Journal of Transplantation)
Diagnosis and treatment of Clostridium difficile in adults (JAMA)
A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy (The Journal of Heart and Lung Transplantation)

Don't be left behind. Click here to see what else you missed.
 



AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Julie Bernhard, Executive Editor, 469.420.2647  
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
May 8, 2015
May 1, 2015
April 24, 2015
April 17, 2015



Advertisement



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063